KKR is buying Envision Healthcare in a nearly $10B deal | AP business

Adjust Comment Print

Envision Healthcare (NYSE:EVHC) shares have been decreased to a Hold rating by equity research analysts at Robert W. Baird. During the same period in the previous year, the firm earned $0.77 EPS. analysts anticipate that Envision Healthcare will post 3.39 EPS for the current year. SunTrust maintained it with "Buy" rating and $40.0 target in Wednesday, December 20 report. Including debt, the deal is worth $9.9 billion.

Envision is based in Nashville, according to Monday's stories. The stock of Envision Healthcare Corporation (NYSE:EVHC) earned "Buy" rating by Raymond James on Tuesday, December 12. They expect $0.80 earnings per share, up 1.27 % or $0.01 from last year's $0.79 per share. Envision Healthcare had a net margin of 1.41% and a return on equity of 4.59%. The firm also took WebMD Health Corp WBMD.O private for about $2.8 billion.

Ryan Daniels, an analyst with William Blair, said the purchase price was a fair multiple for Envision given a number of headwinds facing the industry. Canaccord Genuity upped their price objective on Envision Healthcare from $46.00 to $48.00 and gave the company a "buy" rating in a report on Wednesday, May 9th.

The acquisition agreement comes on the heels of KKR's announcement that it will buy USA business software company BMC Software in a deal that values the company at about $8.5 billion, including debt. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have assigned a buy rating to the company's stock. The firm has "Hold" rating given on Tuesday, April 10 by Cantor Fitzgerald.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Envision Healthcare Corporation ("Envision Healthcare" or "the Company") (NYSE: EVHC News) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to KKR & Co. The stock now has an average rating of "Hold" and an average target price of $41.10.

Several large investors have recently added to or reduced their stakes in EVHC.

Envision's shares were up 2.4 percent at US$44.7 in premarket trading. Broadview Advisors LLC owned about 0.14% of Envision Healthcare at the end of the most recent quarter. Finally, M&T Bank Corp boosted its position in shares of Envision Healthcare by 33.6% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. increased its stake in shares of Envision Healthcare by 88.2% in the fourth quarter. The fund owned 129,752 shares of the company's stock after selling 32,353 shares during the period.

Shares of NYSE EVHC opened at $43.57 on Friday. For example, shares of Envision Healthcare stock have traded at $134.13 per share and an analyst has set a $51.00 per share price target for the stock. The stock has a market cap of $5.29 billion, a P/E ratio of 18.00, a P/E/G ratio of 0.99 and a beta of 0.46.

Envision Healthcare Corporation (NYSE:EVHC) has declined 22.24% since June 12, 2017 and is downtrending. The firm operates through three reportable divisions: Physician Services, Medical Transportation, and Ambulatory Services.

Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States.